Graphene used to identify cancerous cells
Scientists at Chicago’s University of Illinois have discovered what they claim is the first method of detecting cancer using graphene.
By interfacing brain cells onto graphene, the researchers were able to differentiate a single hyperactive cancerous cell from a normal cell. It’s believed the discovery could pave the way for a relatively straightforward, noninvasive diagnostic tool for detecting the disease.
Graphene’s single layer of carbon atoms share a cloud of electrons that move freely around its surface, making it extremely sensitive to changes. Compared to healthy cells, the hyperactivity of cancerous cells leads to a higher negative charge on the graphene’s surface, resulting in the release of more protons, and a change in the atomic vibration energy in graphene's crystal lattice structure. This change is mapped using Raman spectography with a resolution of 300 nanometres.
"This graphene system is able to detect the level of activity of an interfaced cell," said Vikas Berry, associate professor and head of chemical engineering at UIC, who led the research.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Comment: The UK is closer to deindustrialisation than reindustrialisation
"..have been years in the making" and are embedded in the actors - thus making it difficult for UK industry to move on and develop and apply...